CardioFocus has raised $13 million in a new round of mixed financing, according to an SEC filing posted this week.
Money in the round comes from a single unknown investor, according to the filing, with the first sale noted as having occurred on April 4.
The Marlborough, Mass.-based company said that $2.6 million from the offering will go towards sales commissions and finders fees, according to the filing.
CardioFocus is seeking an additional $8 million before closing the offering, bringing the total it hopes to raise up to $21 million.
In February, CardioFocus said that it launched a clinical trial for the latest iteration of its HeartLight direct-visualization ablation device for treating atrial fibrillation.
DeviceTalks West is just a few days away. Join more than 300 of your peers for a day of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.
Don’t miss out on this premier opportunity to come together and share perspectives with the best of the best in the industry.
Use code LASTCHANCE to save an additional 20%.